Foster Rosenblatt

Predictive Analytics & Forecasting

Practice Leaders

Jas Madan
jmadan@fosterrosenblatt.com  |  +1 647 292 4679
Anna Czarnecki, MBA
aczarnecki@fosterrosenblatt.com  |  +1 514 891 6244

Practice Overview

This practice provides advanced predictive analytics and forecasts that quantify future performance of products and markets.

Value Proposition

  • Strategic assessment of opportunities for markets, brands & business units
  • Accurate forecasting of units and/or patients for brands & markets
  • Simulation of markets with computer-based scenario games
  • Characterization & quantification of risk under conditions of uncertainty

Use Cases

Opportunity Assessment

  • Defining, evaluating and planning for different scenarios
  • Conducting quantitative & qualitative war games
  • Establishing decision frameworks for multifactorial issues

Forecasting

  • Forecasting products in early & late stage development
  • Forecasting launch brands for first 18-24 months
  • Forecasting in-market products in either growth or LOE stages

Methods

Epidemiology Based Modeling
For newer or fast changing markets, we use an epidemiology based approach that determines a utilization cascade and projects market evolution over time.
Patient Flow / Systems Methods
This subset of epi modeling uses simulation techniques that follow patient cohorts over time & under changing circumstances.
Demand Based Methods
For established markets or brands, we use a demand basis for modeling that focuses on quantitative time series methods & insightful analog selection.
Modeling Uncertainty
As appropriate, we use dynamic simulators that allow “what if” gaming, scenario optimization & Monte Carlo analyses.

Bloomberg

In addition to our core work for our biopharmaceutical clients, Foster Rosenblatt exclusively provides the market and epidemiology models for the Bloomberg Terminal. Our work is the standard on Wall St. and among the global investment community as a content-rich and reliable source of forward-looking analyses of markets, drugs and epidemiology.